What is Sagimet Biosciences Inc. Series A Common Stock's Market Cap?

Sagimet Biosciences Inc. Series A Common Stock's Market Cap is $665.7M, based on as-reported figures from SEC (XBRL) filings.

What is Sagimet Biosciences Inc. Series A Common Stock's Enterprise Value?

Sagimet Biosciences Inc. Series A Common Stock's Enterprise Value is $425.6M, based on as-reported figures from SEC (XBRL) filings.

What is Sagimet Biosciences Inc. Series A Common Stock's Net Income (TTM)?

Sagimet Biosciences Inc. Series A Common Stock's Net Income (TTM) is -$47.1M, based on as-reported figures from SEC (XBRL) filings.

What is Sagimet Biosciences Inc. Series A Common Stock's Diluted EPS (TTM)?

Sagimet Biosciences Inc. Series A Common Stock's Diluted EPS (TTM) is -0.76, based on as-reported figures from SEC (XBRL) filings.

Sagimet Biosciences Inc. Series A Common Stock (SGMT) Financial Statements

Sagimet Biosciences Inc. Series A Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG0020584Z8

XNAS · usd

10.71▼ 0.23 (-2.10%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close10.94

Day's Range10.65 – 11.17

52-Week Range4.50 – 11.24

Volume804.4K

Avg Volume1.2M

Share Statistics

Shares Outstanding

Employees16

ExchangeXNAS

Listed2023-07-14

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Sagimet Biosciences Inc. Series A Common Stock (SGMT)

What is Sagimet Biosciences Inc. Series A Common Stock's Market Cap?: Sagimet Biosciences Inc. Series A Common Stock's Market Cap is $665.7M, based on as-reported figures from SEC (XBRL) filings.
What is Sagimet Biosciences Inc. Series A Common Stock's Enterprise Value?: Sagimet Biosciences Inc. Series A Common Stock's Enterprise Value is $425.6M, based on as-reported figures from SEC (XBRL) filings.
What is Sagimet Biosciences Inc. Series A Common Stock's Net Income (TTM)?: Sagimet Biosciences Inc. Series A Common Stock's Net Income (TTM) is -$47.1M, based on as-reported figures from SEC (XBRL) filings.
What is Sagimet Biosciences Inc. Series A Common Stock's Diluted EPS (TTM)?: Sagimet Biosciences Inc. Series A Common Stock's Diluted EPS (TTM) is -0.76, based on as-reported figures from SEC (XBRL) filings.
What is Sagimet Biosciences Inc. Series A Common Stock's Net Debt?: Sagimet Biosciences Inc. Series A Common Stock's Net Debt is -$240.1M, based on as-reported figures from SEC (XBRL) filings.